IN-DATE
2215-10-B: Naslund Medical AB, Gold Anchor 22G x 15cm Echogenic Needle, 0.4mm x 10mm Fiducial Marker
Sign in to add this product to your favorites!
| Price: | $699.00 per box of 10 |
|---|---|
| In Stock: | 0 box of 10 |
| Expiration: | In-Date |
We currently do not have this item in stock, but we can email you as soon as it is available.
AccessGUDID Info
- FDA Product Code: IYE
- FDA Product Code Name: Accelerator, Linear, Medical
- GMDN Term Code: 40808
- GMDN Term Name: Radiological image marker, implantable
- GMDN Term Description: A device intended to be implanted within the body, either temporarily or permanently, to create identifying marks that can be seen on radiographic film or digital images. It is typically in the form of a wire, needle, bead, clip, stent-like tube, washer or fluid, and used to locate and delineate a tumour, lesion, or other site of interest. It is made from materials compatible with the imaging system with which it is intended to be used [e.g., magnetic resonance imaging (MRI), x-ray, or nuclear medicine]; it may be intended for use during radiotherapy procedures.
Manufacturer
Naslund Medical AB is a privately held company based in Sweden, specializing in the development and global distribution of fiducial markers for radiation therapy. Their flagship product, the Gold Anchor, is designed to enhance the precision and effectiveness of radiation treatments by providing clear visibility across various imaging modalities, including kV, CT, and MRI. The Gold Anchor markers are preloaded in industry-leading thin needles, allowing for minimally invasive implantation in multiple organs such as the prostate, breast, liver, pancreas, kidney, adrenal gland, lung, cervix, and other gynecologic organs. This innovative design ensures instant stability and reduces the risk of migration, improving patient safety and treatment outcomes. Naslund Medical operates subsidiaries in the United States, United Kingdom, and France, and collaborates with distributors worldwide to make the Gold Anchor accessible to healthcare providers globally.
